Moolec Science SA Files 6-K with Interim Financials
Ticker: MLECW · Form: 6-K · Filed: Jun 28, 2024 · CIK: 1937737
Sentiment: neutral
Topics: financials, 6-K, interim-report
TL;DR
Moolec Science SA dropped its Q1 2024 financials. Check the 6-K.
AI Summary
Moolec Science SA filed a Form 6-K on June 28, 2024, to report its unaudited interim condensed consolidated financial statements as of March 31, 2024, and June 30, 2023. The filing covers the nine and three-month periods ended March 31, 2024, and 2023, and indicates the company will file annual reports under Form 20-F.
Why It Matters
This filing provides investors with updated financial information for Moolec Science SA, allowing them to assess the company's performance and financial health.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- Moolec Science SA (company) — Registrant
- March 31, 2024 (date) — Financial statement date
- June 30, 2023 (date) — Financial statement date
- June 28, 2024 (date) — Filing date
FAQ
What type of financial statements are included in this 6-K filing?
The filing includes unaudited interim condensed consolidated financial statements.
What are the specific dates for which financial statements are provided?
The financial statements are as of March 31, 2024, and June 30, 2023, and for the nine and three-month periods ended March 31, 2024, and 2023.
What is the filing date of this Form 6-K?
The filing date is June 28, 2024.
Under which SEC form does Moolec Science SA file its annual reports?
Moolec Science SA indicates it files annual reports under Form 20-F.
What is the principal executive office address of Moolec Science SA?
The principal executive offices are located at 17, Boulevard F. W. Raiffeisen L-2411 Luxembourg, Grand Duchy of Luxembourg.
Filing Stats: 184 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-06-28 15:01:05
Filing Documents
- ea0208570-6k_moolec.htm (6-K) — 9KB
- ea020857001ex99-1_moolec.htm (EX-99.1) — 348KB
- 0001213900-24-057118.txt ( ) — 358KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2024 Commission File Number: 001-41586 MOOLEC SCIENCE SA (Exact name of Registrant as Specified in Its Charter) 17, Boulevard F. W. Raiffeisen L-2411 Luxembourg, Grand Duchy of Luxembourg (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT LIST Exhibit No. Description 99.1 Moolec Science SA unaudited interim condensed consolidated financial statements as of March 31, 2024 and June 30, 2023 and for the nine and three-month periods ended March 31, 2024 and 2023. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MOOLEC SCIENCE SA (Registrant) Dated: June 28, 2024 By: /s/ Gastón Paladini Name: Gastón Paladini Title: Chief Executive Officer 2